. 2008 Feb;19(2):388–395. doi: 10.1681/ASN.2007040461

Table 3.

Spearman Rank correlations between investigated variables and proteinuria and endothelial function (FMD) in all proteinuric patients and in the separate groups

	All Proteinuric Patients (n = 121)		Nonnephrotic Proteinuria (<3.5 g/d) (n = 43)		Nephrotic-Range Proteinuria without Amyloidosis (>3.5 g/d) (n = 39)		Nephrotic-Range Proteinuria with Amyloidosis (>3.5 g/d) (n = 39)
	Proteinuria (mg/d)	FMD (%)	Proteinuria (mg/d)	FMD (%)	Proteinuria (mg/d)	FMD (%)	Proteinuria (mg/d)	FMD (%)
Age, yr	NS	NS	NS	NS	NS	NS	NS	NS
GFR, ml/min per 1.73 m²	0.27^a	NS	NS	NS	NS	NS	NS	NS
Serum albumin, g/dl	−0.60^b	0.48^b	−0.34^a	NS	NS	NS	NS	NS
BMI, kg/m²	NS	NS	NS	NS	NS	NS	NS	NS
hsCRP, mg/L	0.47^b	−0.40^b	0.53^b	NS	−0.26^a	−0.43^b	0.68^b	−0.54^b
HOMA	0.32^b	−0.31^a	NS	NS	NS	NS	0.37^a	NS
Triglycerides, mg/dl	0.64^b	−0.38^b	NS	NS	NS	NS	NS	NS
Total Cholesterol, mg/dl	0.57^a	−0.25^a	NS	NS	0.33^a	NS	NS	NS
LDL Cholesterol, mg/dl	0.60^b	−0.38^b	NS	NS	NS	NS	NS	NS
Proteinuria, mg/d	NA	−0.55^b	NA	NS	NA	NS	NA	−0.51^b
FMD, %	−0.55^b	NA	NS	NA	NS	NA	−0.51^b	NA
L-Arginine, μmol/L	−0.27^a	NS	NS	NS	NS	NS	NS	NS
L-Arginine/ADMA	−0.88^b	0.59^b	−0.68^b	NS	−0.91^b	NS	−0.47^b	0.41^b
SDMA, μmol/L	0.85^b	−0.58^b	0.72^b	NS	0.77^b	NS	0.39^a	−0.39^a
ADMA, μmol/L	0.88^b	−0.60^b	0.83^b	NS	0.93^b	NS	0.43^b	−0.42^b

NA, not applicable; NS, not significant.

P < 0.05;

P < 0.001.